Funded Tech Companies
Epsilogen
Epsilogen is a biopharmaceutical company, based in London. Venture investment and financing was provided by Novartis Venture Fund, Caribou Asset Management and Schroder Adveq.
Company Overview
Company Name
Epsilogen
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
London BioScience Innovation Centre 2 Royal College St.
London, NW1 0NH
UK
London, NW1 0NH
UK
Phone
Website
Email Address
Company Background Information
Overview
Epsilogen is a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/2/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Timothy Wilson
Chief Financial Officer
Ian Ardill
Chief Scientific Officer
Kevin FitzGerald
Company Investors
- Novartis Venture Fund (Marianne Uteng)
- Caribou Asset Management
- Schroder Adveq
- Epidarex Capital (Peter Finan)
- British Patient Capital
- UCL Technology Fund
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs